Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search
  1. Home
  2. News & events
Filter by
  • Filter by
  • Remove this filter Infectious disease: Vaccine preventable diseases
  • Remove this filter Infectious disease: Influenza
  • Remove this filter Infectious disease: Influenza in humans, seasonal
  • Remove this filter Infectious disease: Influenza A (H1N1)2009
  • Remove this filter Infectious disease: Influenza A (H1N1)
  • Remove this filter Infectious disease: Seasonal influenza
  • Remove this filter Infectious disease: Flu
  • Remove this filter Public health area: Vaccine safety
  • Infectious disease
    • Vaccine preventable diseases (17)
    • Influenza (17)
    • Influenza in humans, seasonal (17)
    • Influenza A (H1N1)2009 (17)
    • Influenza A (H1N1) (17)
    • Seasonal influenza (17)
    • Flu (17)
    • Respiratory diseases (17)
    • Influenza in humans, pandemic (4)
  • Public health area
    • Vaccine safety (17)
    • Immunisation (17)
    • Vaccination (17)
    • Active immunisation (17)
  • Country
    • Europe (8)
  • Media type
    • News (15)
    • ECDC comment (14)
    • Event (2)
  • All (17)
  • News (15)
  • News (15)
  • Page 1 of 2 // 17 Results found
    • Sort by:
Feb 2012

Event

Training workshop on vaccine safety for Member States, building on the experience obtained in the ECDC vaccine safety project VAESCOArchived

Event
23 Feb 2012 - 24 Feb 2012
Stockholm, Sweden
ECDC

ECDC organised a workshop aimed at the Member States not participating in the ECDC Vaccine safety network.

  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety
Oct 2015

Event

Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines

Event
23 Oct 2015
Geneva, Switzerland
International Alliance for Biological Standardisation and the World Health Organization

​This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.

  • EU/EEA
  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, pandemic
  • Influenza in humans, seasonal
  • Vaccine safety

News

ECDC – VAESCO investigation into narcolepsyArchived

ECDC comment - 2 Feb 2011

This initiative was taken following the indication of a potential association between the 2009 pandemic influenza A(H1N1) monvalent vaccine and the occurrence of narcolepsy following reports, especially in children from Finland and Sweden.

  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

News

Reports of cases of narcolepsy and cataplexy in children and adolescents in Finland, Iceland, and SwedenArchived

ECDC comment - 2 Mar 2011

In February 2011, ECDC published a report concerning a rise in narcolepsy in children and adolescents in some northern countries.

  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

News

Swedish MPA publishes interim results of a cohort study assessing the risk of narcolepsy after vaccination with Pandemic influenza vaccine Pandemrix®Archived

ECDC comment - 30 Mar 2011

A four-fold increased incidence of narcolepsy in vaccinated children/adolescents compared to unvaccinated children was observed in this register-based cohort study.

  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

News

Narcolepsy following pandemic influenza A H1N1 2009 vaccination - ECDC update: the European Medicines Agency interim measures for PandemrixArchived

ECDC comment - 27 May 2011

In late March, 2011 ECDC reported that the Swedish Medical Product Agency published preliminary results from an on-going cohort study involving 5.3 million people, where 67% of children and adolescents and 51.0% of adults were vaccinated with Pandemrix.

  • Immunisation
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

News

European Medicines Agency (EMA) 2009 Influenza Pandemic EvaluationArchived

ECDC comment - 30 May 2011

The European Medicines Agency (EMA) was key in the Europe during the 2009 pandemic concerning the authorisation and the benefit – risk assessment of the novel pandemic vaccines.

  • Immunisation
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

News

Case inventory study from Sweden concerning association of Pandemrix vaccination and reports of narcolepsy with cataplexy in children and adolescentsArchived

ECDC comment - 1 Jul 2011

ECDC has previously summarised information concerning the appearance of narcolepsy following the use of a specific pandemic vaccine (Pandemrix®) in children and adolescents in three European Countries.

  • Europe
  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

News

Recommendation by the European Medicines Agency concerning Pandemrix vaccination and reports of narcolepsy in children and adolescentsArchived

ECDC comment - 21 Jul 2011

EMA recommends restricting use in persons under 20 years of age Pandemrix to be used only in the absence of seasonal trivalent influenza vaccines, following link to very rare cases of narcolepsy in young people. Overall benefit-risk remains positive.

  • EU/EEA
  • Immunisation
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine preventable diseases
  • Vaccine safety

News

Association of childhood narcolepsy and cataplexy and receipt of a pandemic influenza vaccine in Finland in 2009-10 – First papers in a peer review journalArchived

ECDC comment - 30 Mar 2012

​A pair of linked papers from Finland concerning the above topic, one epidemiological and the second combining both clinical and epidemiological were published on March 28th in the open access journal, PLoS One.(1,2).

  • Finland
  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

Pagination

  • Current page 1
  • Page 2
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us